Eclipse Bioinnovations
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $12M
Investors
- 4
About Eclipse Bioinnovations
Based in California, US, and founded in 2017 by its CEO, Peter Chu and co-founder, Alexander Shishkin, Eclipse Bioinnovations, Inc. operates as an RNA genomics company that provides products and services to academic and industry customers. In September 2021, Eclipse Bioinnovations, Inc. Eclipse Bioinnovations, Inc. offers an end-to-end RNA genomics product and service that includes RBP-eCLIP Kit is a preparation method to identify RNA-binding proteins, m6A-eCLIP Kit allows researchers to map m6A RNA modification states, FLI-Seq Kit removes undesired genomic DNA, eCLIP Antibody Validation Kit validates antibodies for immunoprecipitation in eCLIP buffers, and 5' & 3' End-Seq Kits enable the user to detect either 5’ or 3’ transcript ends genome-wide with single-nucleotide resolution. In addition, the company provides custom RNA genomics services.
Who invested in Eclipse Bioinnovations
4 investors across 1 round
See all investors in Eclipse Bioinnovations
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 27, 2021
Amount
$12M
Investors
Questions about Eclipse Bioinnovations
Who invested in Eclipse Bioinnovations?
Eclipse Bioinnovations has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eclipse Bioinnovations raised?
Eclipse Bioinnovations has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eclipse Bioinnovations last raise money?
Eclipse Bioinnovations's most recent round on record is a Series A, in Aug 2021.
What does Eclipse Bioinnovations do?
Based in California, US, and founded in 2017 by its CEO, Peter Chu and co-founder, Alexander Shishkin, Eclipse Bioinnovations, Inc.
Where is Eclipse Bioinnovations headquartered?
Eclipse Bioinnovations is headquartered in San Diego, US.
Which VCs invest in companies like Eclipse Bioinnovations?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eclipse Bioinnovations's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Eclipse Bioinnovations? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.